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Abstract
Many studies have been devoted to understand the mechanisms used by pathogenic bacteria to exploit human hosts.
These mechanisms are very diverse in the detail, but share commonalities whose quantification should enlighten the
evolution of virulence from both a molecular and an ecological perspective. We mined the literature for experimental data
on infectious dose of bacterial pathogens in humans (ID50) and also for traits with which ID50 might be associated. These
compilations were checked and complemented with genome analyses. We observed that ID50 varies in a continuous way
by over 10 orders of magnitude. Low ID50 values are very strongly associated with the capacity of the bacteria to kill
professional phagocytes or to survive in the intracellular milieu of these cells. Inversely, high ID50 values are associated with
motile and fast-growing bacteria that use quorum-sensing based regulation of virulence factors expression. Infectious dose
is not associated with genome size and shows insignificant phylogenetic inertia, in line with frequent virulence shifts
associated with the horizontal gene transfer of a small number of virulence factors. Contrary to previous proposals,
infectious dose shows little dependence on contact-dependent secretion systems and on the natural route of exposure.
When all variables are combined, immune subversion and quorum-sensing are sufficient to explain two thirds of the
variance in infectious dose. Our results show the key role of immune subversion in effective human infection by small
bacterial populations. They also suggest that cooperative processes might be important for successful infection by bacteria
with high ID50. Our results suggest that trade-offs between selection for population growth-related traits and selection for
the ability to subvert the immune system shape bacterial infectiousness. Understanding these trade-offs provides guidelines
to study the evolution of virulence and in particular the micro-evolutionary paths of emerging pathogens.
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Introduction
Bacteria are a significant part of the human body, often
establishing commensal or mutualistic interactions with it [1]. Yet,
some species, or some strains within species, have a significant
negative impact on the host while exploiting its resources. Such
antagonistic associations lead to co-evolution between the two
sides, often in the form of an arms race [2]. Pathogenic bacteria
aim at exploiting the host, which usually involves eluding its
defenses. The known mechanisms for immune evasion are varied
and sophisticated, but nevertheless a few common themes emerge
that are shared between phylogenetically distant bacteria (re-
viewed in [3–6]). Passive mechanisms of immune evasion include
invading immune-privileged locations, antigenic variation, devel-
opment of quiescent states, and modification of the cellular
envelope. Protection from the immune system is even more
effective when bacteria are able to subvert the immune system.
Bacteria that are able to kill professional phagocytes or to survive/
replicate in the intracellular milieu of these cells are mentioned
throughout this text as being able to ‘‘kill or subvert professional
phagocytes’’ or just able to do ‘‘immune subversion’’ (see also
Discussion for possible limitations and extensions of this
definition). Such bacteria may not search to escape the immune
response but rather to stimulate it. This can be advantageous if the
bacteria can grow inside phagocytes or if the immune response
competitively disadvantages neighboring bacteria [7,8]. Effective
subversion of immune cells involves a variety of mechanisms
including induction of stress response to escape reactive oxygen
species, subversion of signaling pathways, inhibition of fusion
between phagosomes and lysosomes, escape into cytoplasm,
production of toxin-killing phagocytes and manipulation of
apoptosis [9,10]. Knowledge of the mechanisms involved in
subverting the immune system is important to effectively control
virulence in clinical settings, but precise identification of the
common themes behind them is essential to understand the
evolution of virulence and its mechanisms [11–13].
Commonalities among strategies used by bacteria to subvert the
host’s immune system suggest the existence of trade-offs shaping
the pathogens’ life-histories [14,15]. Notably, investment in
increasing transmission between hosts often leads to increased
virulence at the cost of faster clearance (or host death) [16,17].
Investment in the control of the host immune system most often
comes at the cost of less efficient extraction of host resources for
growth and transmission [18]. As a result, the forms of the
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efficiency, its cost and its mechanisms, are key parameters shaping
the evolutionary dynamics of the pathogen-host association. One
influential categorization of virulence themes separates frontal-
attack from stealth pathogens, in an analogy with classical military
strategies [19]. Frontal-attack pathogens would have limited
capacity to deal with the immune system, especially its adaptive
component, producing acute diseases by growing fast and by
secreting extracellular toxins that contribute to overwhelm
momentarily the host defenses. Stealth pathogens, on the other
hand, would manipulate efficiently the immune system achieving
more stable associations where slow growth is compensated by
increased persistence. Naturally, there is a gradient between
stealth and frontal-attack strategies resulting from the use of a
multitude of combinations of a variety of mechanisms.
The positioning of a bacterial pathogen in terms of virulence
strategies results from the diverse life-history trade-offs shaping its
evolution. To understand these trade-offs one must be able to
categorize virulence mechanisms and virulence strategies. This
requires empirical analysis of the association between their
infectivity and other physiological and genetic traits such as the
mechanisms of immune subversion, effector secretion, growth
rates, motility or genome size. The mechanisms used to
manipulate host immune responses are expected to be key
determinants of the size of the infectious dose required to start
an infection. Accordingly, it has been proposed that bacteria
coding for secretion systems injecting effectors directly into host
cells using type 3 or type 4 secretion systems (resp. T3SS and
T4SS) are associated with low infectious dose [20]. Direct
secretion allows local manipulation of eukaryotic cells by a small
number of bacteria. On the other hand, extracellular effectors
provided by other secretion systems would have a global action
requiring many cooperating bacterial cells to secrete enough
molecules to be effective [20]. Since the size of the bacterial
population is determinant in the success of infection, many
pathogens show quorum-sensing regulated expression of virulence
factors such as toxins and adhesins [21,22]. In the same line, fast
growth is expected to contribute much more to the success of
frontal-attack than that of stealth pathogens. Additionally,
bacterial motility facilitates dispersion and colonization [23–25]
and allows counteracting peristalsis and mucus flow [26]. But
motility appendages also pose problems: motility facilitates
phagocytosis [27], flagella are costly [28], poorly adapted to
intracellular environments, where bacteria tend to use actin-based
motility [29], and flagellin-mediated activation of dendritic cells is
rapid and highly deleterious to bacterial survival [30]. This
suggests that flagella loss might be adaptive in pathogens with little
need of motility, but strongly selecting for immune evasion. All
these hypotheses are consistent with theoretical arguments and can
be illustrated with examples. Yet, we know of no comparative
study making a statistical assessment of the association of these
variables with infectious dose.
It has been argued that to establish a theory for the evolution of
virulence aiming at explaining differences and similarities between
pathogens one has to bridge the gap between evolutionary ecology
concepts and the mechanistic processes of virulence [11,14,15,31].
In this study we only analyze bacterial pathogens. Bacteria use
very diverse mechanisms of pathogenicity for which there is a large
accumulated body of literature. Instead of attempting to analyze
directly the trade-offs shaping the virulence strategies, which is
difficult even for a single pathogen, we will use a statistical
approach, based on the comparative method, to assess the
associations between eight variables thought to have key roles in
virulence strategies. (i) Infectious dose. (ii) The ability of the
bacteria to kill professional phagocytes or to survive in the
intracellular milieu of these cells. (iii) The minimum generation
time, i.e. the lineage’s ability to grow very fast whenever conditions
are favorable. (iv) The use of quorum-sensing to regulate the
expression of virulence factors. (v) Bacterial motility. (vi) The use of
secretion systems able to deliver protein effectors directly into
eukaryotic cells. (vii) The genome size, which correlates to the size
of the functional repertoire of a bacterium. (viii) The route of
exposure. Our immediate objective was to clarify the factors
relevant for the understanding of variation in ID50 among
bacteria. Our final goal was to complement current approaches,
mostly focused on how a population of parasites evolves in relation
to virulence, by way of an analysis focusing on the common trends
observed in a very diverse panel of bacterial pathogens.
Results
Variation in infectious dose is independent of genome
size, phylogenetic structure and little affected by route of
exposure
ID50 measures the minimum size of a population of infectious
agents required to start an infection with 50% probability. We
computed log-transformed average values of ID50 for all 48
bacterial pathotypes for which we could collect experimental
values in the literature (Figure 1, Table S1 in Text S1). Infectious
dose in humans may significantly differ from that of animal
models. Within humans, ID50 varies with the host health state,
genetic background and the route of exposure [32] (see
Discussion). Therefore, we restricted our analysis to values
obtained from experimental infections of healthy human individ-
uals using natural routes of exposure (see Text S1 for details). The
only exception concerns the use of ID50 data from experiments in
rhesus monkeys for Helicobacter pylori [33]. Exclusion of this species
has no effect on the conclusions of this work. The use of ID50
obtained from human hosts prevents spurious interpretations
when animal models do not adequately represent the human host.
We observe a wide range of ID50 values in our dataset (Figure 1),
from 3 bacterial cells in Orientia tsutsugamushi [34] to more than 10
10
Author Summary
Every pathogen is unique and uses distinctive combina-
tions of specific mechanisms to exploit the human host.
Yet, several common themes in the ways pathogens use
these mechanisms can be found among distantly related
bacteria. The understanding of these common themes
provides useful concepts and uncovers important princi-
ples in pathogenesis. Here, we have made a cross-species
analysis of traits thought to be relevant for virulence of
bacterial pathogens. We have found that the infectious
dose of pathogens is much lower when they are able to kill
professional phagocytes of the immune system or to
survive in the intracellular milieu of these cells. On the
other hand, bacteria requiring higher infectious dose are
more likely to be motile, fast-growing and regulate the
expression of virulence factors when the population
quorum is high enough to be effective in starting an
infection. This suggests that infectious dose results from a
trade-off between selection for fast coordinated growth
and the ability to subvert the immune system. This trade-
off may underlie other traits such as the ability of a
pathogen to live outside the association from a host.
Understanding the patterns shaping infectious dose will
facilitate the prediction of evolutionary paths of emerging
pathogens.
Determinants of Infectious Dose
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separating high and low ID50 values. Bimodality of ID50 values
could have arisen from perfectly dichotomic virulence strategies,
e.g. stealth versus frontal [19]. Instead, our data is consistent with a
continuum of ID50 values, suggesting that more complex trade-
offs shape the virulence strategies of bacterial pathogens.
Genome size in bacteria is directly proportional to the number
of encoded genes and therefore corresponds to its functional
potential [36,37]. In our dataset, the smallest genomes are found
among obligatory pathogens whereas larger genomes are associ-
ated with facultative pathogens [38]. This could impact infectious
dose. However, we found no significant correlation between
genome size and ID50 (Spearman rho=0.18, p=0.23), or
between the number of genes in genomes and ID50 (Spearman
rho=0.20, p=0.19). This is in line with low infectious dose in
bacteria with genome sizes as diverse as the Rickettsia (,1 Mb) and
Burkholderia pseudomallei (7 Mb). We will therefore ignore the
variable genome size in the subsequent analyses.
We have also analyzed the association between ID50 and the
route of exposure. We classed these routes into three categories:
ingestion, inhalation or other routes (including intravenous and
urogenital) (Table S1 in Text S1). There is a weakly significant
difference in terms of ID50 between these groups (p=0.024,
Wilcoxon test; p=0.04, ANOVA), such that bacteria that are
ingested tend to have a higher ID50 (median 1 000 000 vs 1000
for inhaled and 40 for other routes). This difference is weak.
Analysis using Tukey-Kramer HSD tests do not show significant
differences in ID50 between pairs of classes (p.0.05), and pairwise
t-tests are at the edge of statistical significance (p=0.03). We have
not found enough data to compare the ID50 of different routes of
exposure for the same pathotype. Most bacteria have one single
most frequent route of exposure, the one for which we collected
the experimental data. As a consequence, the values of ID50
following unnatural routes are difficult to interpret in an
evolutionary context. The higher ID50 among ingested bacteria,
relative to the other routes is not very surprising given the effects of
stomach acidity on bacterial viability [39].
Closely related strains of diverse pathotypes show large
differences in ID50. An extreme case is provided by Escherichia
coli pathotypes, including the Shigella, where ID50 varies between
10 and over 10
9 cells (Table S1 in Text S1). The correlation
between the value of a trait and the organismal phylogenetic
relatedness is given by its phylogenetic inertia. High inertia reflects
important vertical inheritance, in which case closely related
organisms resemble due to their recent common ancestry [40].
We assessed the impact of phylogenetic inertia on the ID50 values,
i.e. we assessed if a significant fraction of the variance in ID50
values can be explained by evolutionary relatedness. For this, we
built the phylogenetic tree linking the 48 pathotypes using the 16S
rRNA subunit (see Materials and Methods) (Figure 2). High
phylogenetic inertia should lead to clusters of ID50 in the
phylogenetic tree. Instead, using both the Blomberg’s K index
[41] and Pagel’s Lambda index [42] we find no significant
association between variation in ID50 and phylogenetic related-
ness (K=0.000394, p=0.33; Lambda=8610
205, p=1), indicat-
ing no need to correct ID50 statistical analyses for phylogenetic
structure. These results suggest that adaptation, e.g. by horizontal
gene transfer and pathoadaptive deletions, can quickly erase the
signs of vertical inheritance in ID50.
Figure 1. Histogram of the distribution of infectious dose
values (ID50). Red (blue) represents bacteria unable (resp. able) to kill
or subvert professional phagocytes.
doi:10.1371/journal.ppat.1002503.g001
Figure 2. 16S Phylogenetic tree linking the different patho-
types used in the work and relevant variables: ID50 (infectious
dose), PS (killing of or intracellular survival in professional
phagocytes), QS (virulence regulated by quorum-sensing), M
(motility), SS (direct type 3 and/or type 4 secretion systems), g
(minimum generation time), GS (genome size). The gradients of
color from light to dark represent higher values of the quantitative
variables. For discrete variables the presence of the trait is associated
with dark cells and its absence with white.
doi:10.1371/journal.ppat.1002503.g002
Determinants of Infectious Dose
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We found published experimental data indicating that 34 of the
48 pathotypes are able to kill professional phagocytes or to survive
in the intracellular milieu of these cells (Table S2 in Text S1).
These bacteria are expected to surmount more efficiently the
immune response. We found a striking association between this
trait and infectious dose (Figure 1). The set of bacteria with this
trait has a median infectious dose of 250 cells versus about
30 000 000 cells for the remaining dataset (p,0.0001, Wilcoxon
test) (Figure 3). This trait alone explains 56% of all variance in
ID50 (R
2=0.562, p,0.0001, ANOVA). There is a clear
separation of the two groups of bacteria at the ID50 threshold
of ,10
6 bacterial cells. The two outliers are Neisseria meningitidis
and Clostridium perfringens, having respectively unexpected low and
high ID50 (Figure 3). Several concordant experimental works
indicate that C. perfringens has ID50 values higher than 10
8 cells (see
Table S1 in Text S1) in spite of its production of a toxin capable of
killing macrophages [43]. Relative to other species in this study,
Neisseria cells are specifically protected from complement by
capsules of sialic acid and by the action of surface glycolipid
lipopolysaccharides [44]. Also, N. meningitidis is capable of evading
the immune system by antigenic variation [45]. Hence, the
unexpectedly low ID50 value of N. meningitidis might result from its
efficient use of other means of escaping the immune system.
We then tested the robustness of the association between ID50
and immune subversion. First, we removed Treponema pallidum, for
which literature is somewhat equivocal on its ability to kill or
subvert professional phagocytes (see comments in Table S2 in Text
S1). Removing this species made no qualitative difference
(R
2=0.558, p,0.0001, ANOVA). We then further removed from
the analysis the two pathotypes able to kill professional phagocytes
but for which evidence of intracellular survival is lacking (Table S2
in Text S1), obtaining similar conclusions (R
2=0.560, p,0.0001,
ANOVA). Overall, these results are in excellent agreement with
the hypothesis that the capacity of a bacterium to manipulate the
immune system is a key determinant of the population size
required for infection.
Direct delivery secretion systems are weakly associated
with low infectious dose
Bacteria often use secreted proteins to subvert or kill
professional phagocytes [3]. In particular, it has been suggested
that direct delivery of effectors into the eukaryotic cell allows
bacteria to lower their ID50 [20]. This hypothesis predicts more
frequent presence of T3SS and/or T4SS in low ID50 bacteria. It
does not presume of the eventual presence or absence of other
secretion systems. We therefore identified non-flagellar T3SS and
non-conjugative T4SS in the genomes of these pathotypes (see
Materials and Methods, Table S3 in Text S1, Table S4 in Text
S1). This list includes all experimentally validated systems in the
pathotypes, most of which were shown experimentally to be
implicated in pathogenesis. Our analysis shows weakly significant
lower ID50 for bacteria using T3SS or T4SS in pathogenesis (resp.
medians of 150 and 80 000, p=0.034, Wilcoxon test, p=0.072,
ANOVA). We tested the robustness of this analysis in several
independent ways. Firstly, we excluded bacteria with cellular
envelopes for which no direct delivery secretion systems are known
(firmicutes, tenericutes, actinobacteria). Differences among the
remaining (diderm) bacteria having and lacking T3SS/T4SS in
terms of ID50 are not significant (p=0.09, Wilcoxon test, p=0.2,
ANOVA). Secondly, we included type 6 secretion systems (T6SS)
in the analysis, some of which are also capable of delivering
effectors into eukaryotic cells [46,47]. Bacteria with genomes
encoding at least one of the three secretion systems (T3SS, T4SS
or T6SS) are not significantly different from the others in terms of
ID50 (p=0.42, Wilcoxon test, p=0.64, ANOVA). Thirdly, we
removed from the analysis the three pathotypes lacking evidence
of being able to survive inside professional phagocytes (Table S2 in
Text S1) and this rendered the tests scarcely more significant
(p=0.03, Wilcoxon test, p=0.04, ANOVA). Finally, bacteria with
genomes encoding T3SS or T4SS have a slightly higher
probability of being able to kill or subvert professional phagocytes
(p=0.054 and p=0.026, Fisher’s exact test, resp. for all genomes
and for diderms only). We conclude that the evidence is weak for
an association between the use of direct delivery protein secretion
systems and low ID50 values.
High infectious dose pathogens are more often motile,
grow faster and use quorum sensing
The information for motility was taken from the literature [48]
and checked by genome analysis (Table S4 in Text S1). Motile
bacteria are associated with higher than expected values of ID50
(resp. medians 300 000 and about 150 for non-motile bacteria,
p=0.013, Wilcoxon test and p=0.02, ANOVA, Figure 4). Motile
bacteria are also less often able to kill or subvert professional
phagocytes (p=0.030, Fisher’s exact test). Redoing the analysis by
marking Yersinia pseudotuberculosis and Listeria monocytogenes as non-
motile (Table S5 in Text S1), since they down-regulate motility
when expressing virulence factors [49,50], makes no qualitative
difference (p,0.03, both for Wilcoxon test and ANOVA).
Detailed statistical analysis of the effect of the differences between
mechanisms of motility on ID50 was not possible because all but
two bacteria in our dataset (Mycoplasma pneumoniae and Haemophilus
ducreyi) use the same mechanisms of motility (flagella). Exclusion of
these two bacteria did not significantly affect the association
between motility and ID50 (p=0.012, Wilcoxon test and
p=0.019, ANOVA) or the ability to kill or subvert professional
phagocytes (p=0.036, Fisher’s exact test).
It has been proposed that frontal-attack pathogens compensate
their high infectious dose and lower capacity to subvert the
immune system by growing quickly. Fast coordinated growth
Figure 3. Association between infectious dose (ID50) and the
capacity of pathogens of killing professional phagocytes or
surviving inside professional phagocytes. Edges of the mean
diamonds indicate the interval of confidence (95%) of the mean. The
center of the diamond indicates the average. Outliers are labeled.
doi:10.1371/journal.ppat.1002503.g003
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propagation before clearance [19,20]. We thus tested the
hypothesis that high ID50 pathogens tend to grow quickly under
favorable conditions and to use quorum-sensing to regulate the
expression of virulence factors. Indeed, the lowest experimentally
determined minimal generation times [51](Table S5 in Text S1)
are found among the pathogens with highest ID50 (Spearman’s
rho=20.41, p,0.01, Figure 4). On the other hand, low ID50
bacteria include fast and slow growers. This is not unexpected
since fast growers can grow slowly by way of genetic regulation
whereas slow growers, by definition, never grow fast. This suggests
that the capacity to grow fast is important for pathogens with high
ID50 but less relevant for the others.
We then identified from the literature the bacteria with
experimental evidence of using quorum-sensing to regulate the
expression of virulence factors (Table S6 in Text S1). Such
pathogens do have a significantly higher median infectious dose
than the other bacteria (resp. 1 000 000 and 45, p,0.0005, both
for Wilcoxon test and ANOVA). As expected, there is also a
significant association between quorum-sensing and minimal
generation times (p,0.005, both for Wilcoxon test and ANOVA)
and between both variables and the ability of a pathogen to kill or
subvert professional phagocytes (p,0.05, for both variables).
Thus, motility, fast growth and quorum-sensing based regulation
of virulence factors are associated with bacteria with high
infectious dose.
Immune subversion and quorum-sensing are major
determinants of infectious dose
Many of the variables studied in this work are associated with
ID50 and with each other. To disentangle their respective effects
we made a forward stepwise regression analysis of the effect of
these variables on ID50 (same results for mixed and backward
stepwise regressions). The ability of a pathogen to kill or subvert
professional phagocytes is the major explanatory variable of
infectious dose (R
2=0.562, p,0.0001), followed by quorum-
sensing based regulation of virulence factors (+10%, cumulated
R
2=0.657, p,0.001). This shows that ,66% of the variance in
the ID50 values of our dataset can be explained by just two
variables. The other variables have no further significant
contribution to the regression (using both F-test or Akaike’s
criterion [52], Table 1). Hence, immune subversion and quorum-
sensing are sufficient to explain all variance that can be explained
by our set of variables.
Discussion
We used methodological approaches commonly used in
evolutionary ecology and comparative genomics to quantify the
association of certain virulence-related traits with infectious dose.
Such empirical approaches may help bridge the gap between
theory in evolutionary ecology and knowledge of the molecular
mechanisms of virulence [3,19,31]. To test quantitatively these
ideas we put together variables expected to be both relevant for the
mechanisms of virulence and quantifiable in very different
organisms. Biological processes linked with immune defense are
complex and the precise mechanisms used by pathogens to
confront it can be very diverse. As a result, finding variables that
can highlight commonalities among pathogens is challenging.
Here, we have focused our attention on one set of traits associated
with immune subversion: the pathogen’s ability to kill and/or
survive and/or replicate in professional phagocytes. These traits
have been assessed extensively among pathogens and are
important for virulence strategies. Our simplified approach
remains meaningful, since we were able to explain a significant
fraction of the variance of infectious dose. Future work should aim
at further including strategies such as phagocytosis avoidance,
interference with opsonization, antigenic variation, induction of
immunopathology or taking refuge inside non-immune cells
[3,10,53], for which systematic cross-species data is not yet
available.
Figure 4. Positive association between ID50 and traits involved in cooperative growth and dispersal. We depict the association of ID50
with quorum-sensing regulated virulence (left), cell motility (center) and minimal generation time (right). Edges of the mean diamonds indicate the
interval of confidence (95%) of the mean. The center of the diamond indicates the average. Outliers are labeled. The color of points depicts the values
of the first variable. Blue: no information on the use of quorum-sensing to regulate the expression of virulence factors. Red: evidence for the
regulation of expression of virulence factors by quorum-sensing.
doi:10.1371/journal.ppat.1002503.g004
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underlying data. Some variables, e.g. genome size, motility,
secretion systems, were quantified on the basis of extensive
genome data and were in excellent concordance with the
literature. Minimum generation times, quorum-sensing regulated
expression of virulence factors and the capacity of bacteria to resist
to professional phagocytes are all extensively studied in the
literature. Naturally, we cannot exclude the possibility that future
studies may lead to revision of some of these numbers. To assess
the robustness of our findings we have made a number of
supplementary analyses where we exclude more doubtful data
points. These analyses invariably confirmed the main conclusions
of this work. One further source of complications in this type of
analyses results from the variation of traits within pathotypes. Lack
of published data forced us in a few cases to use more than one
strain of a given pathotype to gather the information on the full set
of traits used in the statistical analyses. Variability between strains
can add noise to the data and decrease association measures.
Nevertheless, the traits with lower association measures in this
study, motility, genome size, secretion systems, could be analyzed
using data from both literature and genome data. The two sources
of data were in general concordant suggesting the robustness of
our analyses. Also, we found little variation in these traits among
the genomes of the strains of the same pathotype. Estimation of
accurate ID50 values for bacterial pathogens is more difficult
because of a number of factors including variation in the route of
exposure, host health condition and genetic background [32,54].
To reduce these sources of variation we averaged over multiple
references of ID50 and used experimental values obtained from
natural exposure routes in healthy humans (see Text S1). It has
been suggested that ID50 does not adequately characterize the
relative hazard of pathogenic organisms in humans [55]. Our
results argue strongly against this perspective. If variation in ID50
were biologically irrelevant, or its measurement too noisy, then
one could not have explained 66% of its variance with two
pertinent biological variables. The existence of quorum-sensing
based regulation of virulence shows in itself the relevance of
infectious dose for virulence strategies. For obvious ethical and
technical reasons, new ID50 values in humans have become
almost impossible to obtain. Therefore, it will be important to
study the relation between ID50 data in humans, as used in our
work, and data obtained from model organisms. This would allow
extending the dataset of ID50 and broaden the scope of these
analyses.
Motility is less frequently found among bacteria with low ID50
and among bacteria able to kill or subvert professional phagocytes.
This is in agreement with a series of observations. Listeria
monocytogenes and Yersinia enterocolitica switch-off motility when up-
regulating virulence factors [49,50]. Loss of flagella is associated
with the emergence of Bacillus anthracis lineages within the B. cereus
clade [56], and with immune evasion in Pseudomonas aeruginosa [57].
These results point to a trade-off between motility and
infectiousness, whereupon low ID50 bacteria tend to be non-
motile, presumably as a result of investment on immune evasion
and the use of actin-based motility in intracellular environments
[29]. On the other hand, high ID50 bacteria are motile, possibly
because this facilitates grouping, chemotaxis, transmission and life
outside the host.
We found little supporting evidence for the proposal that
secretion systems capable of direct delivery of protein effectors into
eukaryotic cells are important determinants of low infectious dose
[20]. Protein secretion by T3SS and T4SS plays essential roles in
ecological interactions of pathogens and mutualists and is
widespread among proteobacterial pathogens [58–60]. However,
many bacteria lacking such systems have low ID50 and efficiently
subvert macrophages, e.g. Mycobacterium tuberculosis [61]. This does
not necessarily contradict the idea that virulence strategies are
affected by the range of secreted proteins leading to local versus
global effects [20]. In fact, protein secretion in very viscous
environments or inside professional phagocytes is effectively local,
independently of being done by T3SS/T4SS or by secretion
systems targeting proteins to the extracellular environment. While
the categorization of global and local effectors might still be
pertinent, our data suggests it is not directly traceable from the
identification of the respective secretion system. Furthermore,
many bacteria use multiple means of secretion. For example, H.
pylori blocks antigen-dependent proliferation of T-cells and
suppresses B-cell apoptosis [62–64], which depend respectively
on the secretion of VacA into the extracellular space [65] and
CagA into the eukaryotic cell by a T4SS [66]. Thus, whether the
secretome acts locally or globally might be less dependent on the
nature of the secretion system and more on the bacterial micro-
environment and the coordinated action of the different effectors.
Selection for quorum-sensing based regulation of the expression
of virulence factors among high ID50 pathogens is expected since
these bacteria can only effectively infect their hosts when their
quorum is above a certain threshold. Quorum-sensing may be
required to the establishment of cooperative processes, e.g.
productive extracellular secretion of virulence factors [67].
However, such cooperative behavior can be prone to exploitation,
especially in the case of multiple infections [68], if cooperating
pathotypes can be outgrown by non-cooperating pathotypes with
Table 1. Results of the full and stepwise multiple regressions of ID50 with the other variables.
Variable individual R
2 cumulative R
2 Prob.FA I C
Subversion of professional phagocytes 0.562
++ 0.562 ,0.00001 66.05
Virulence regulated by quorum-sensing 0.262
++ 0.657 0.001 56.25*
Route of exposure 0.127
+ 0.665 NS 56.66
Motility 0.109
+ 0.666 NS 58.63
Direct secretion systems (T3SS+T4SS) 0.068
NS 0.666 NS 60.00
Minimal generation time 0.106
+ 0.670 NS 61.30
Variables are ordered by cumulative explanatory power in the stepwise regression from highest (top) to lowest (bottom). Both the R
2 of the individual regressions
(individual R
2) and the cumulative effect of the variables on the stepwise regression (cumulative R
2) are provided. For the latter, the statistical tests for the relevance of
the inclusion of each variable in the stepwise regression are also given (F-test and Akaike’s criterion). Statistical thresholds:
++ (p,0.001),
+ (p,0.05), NS (p.0.05).
*minimum by the AIC criterion.
doi:10.1371/journal.ppat.1002503.t001
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high ID50 bacteria grow fast. Interestingly, we find that high
ID50 bacteria are more likely to enter the human body by
ingestion. Since the oral cavity and the gut are the most diverse
environments of the human body, bacteria in these environments
are likely to face social dilemmas more frequently, and this could
place particularly strong selection on growth rates, motility and
cooperation by quorum-sensing. Conversely, bacteria that are
introduced by insect vectors in the body experience little
competition from other pathogens, and we find that they tend
to grow slowly and have low ID50. Fast growth among high
infectious dose bacteria also creates the demographic conditions
allowing the population to counteract rapid immune clearance, as
proposed in the frontal-attack model [19]. On the other hand,
investment in immune evasion carries a metabolic cost that might
implicate slow growth among stealth pathogens [70]. Further-
more, persistence might be favored under slow growth [71]. This
suggests a trade-off between growth rate and immune subversion
that could drive the evolution of frontal-attack or stealth
strategies.
The ability of bacteria to kill or subvert professional phagocytes
has by far the largest explanatory power over ID50 variation in
our analysis. The lack of correlation between these two traits and
genome size suggests that none of it requires a large catalogue of
genetic information. The lack of significant phylogenetic inertia
in ID50 clearly shows the potential for rapid evolution of
infectious dose, e.g. by transfer or deletion of virulence factors
[72,73]. The observed large range of ID50 values is likely to
result from a conjugation of factors. Immune subversion results
from mechanisms with different costs and efficacies. These
mechanisms are involved in trade-offs with traits that are
adaptive in non-antagonistic associations. On this line of thought,
one is inclined to speculate that the development of subversion
skills in obligatory pathogens allows infection at low infectious
dose, at the cost of poor growth outside of the host. Facultative
pathogens would require higher infectious dose because they tend
to remain less competent at immune subversion. Bacteria within
these latter clades often receive by horizontal transfer genes
rendering them more competent at immune subversion. Occa-
sionally, some of these lineages emerge as specialists that are apt
to immune subversion. This will lead or be accompanied with the
evolution of lower ID50. Examples of such lineages include the
Shigella, Yersinia pestis and Bacillus anthracis. Such adaptive shifts
lead to lower growth rates and sexual isolation [74]. These costs
lead to further selection for increased competence at immune




Data was retrieved from RefSeq GenBank Genomes (ftp://ftp.
ncbi.nih.gov/genomes/Bacteria). Annotations were retrieved from
the GenBank files and pseudogenes were ignored. In most cases
there was more than one genome for each pathotype and in those
cases we analyzed the available genomes (Table S3 in Text S1). In
general the different genomes for a given pathotype produced
concordant results in which case we picked one genome randomly
for the phylogenetic analysis. However, in the few cases where
different strains led to different results, we just analyzed the strains
used to produce the infectious dose data. When even such
information was unavailable we used the type-strain. The
accession numbers of the reference strain are indicated in Table
S3 in Text S1.
Identification of secretion systems and flagella
For each system we initially obtained a set of proteins known to
be part of the core of the system (see Supplementary Material for
details). Our references for core proteins were [75,76] for T3SS
[77,78], for T4SS [79], for T6SS and [76] for flagella. For these
core proteins, we performed all against all blast searches and psi-
blast searches among genomes. The hits were then clustered by
sequence similarity with MCL [80]. The resulting protein families
were manually curated. We then constructed multiple sequence
alignments of the families using MUSCLE [81] and subsequently
manually edited the alignments using SEAVIEW [82]. For each of
the protein families, we built sequence profiles with HMMER 3.0
[83]. We then used the same program to perform searches with
our profiles in the genomic sequences. Sets of hits with c-val
,10
23 and aligning at least 50% of the protein profile for a given
genome were further checked for co-localization of the respective
genes within a replicon. These clusters were then analyzed to
pinpoint the relevant systems. T3SS and flagella were separated
based on the identification of one gene specific of non-flagella
T3SS (the secretin) and 3 genes specific of flagella [76]. T4SS
associated with protein transport were identified apart from the
conjugation systems by verifying the lack of a nearby relaxase in
the genome [77,78]. We then checked extensively that our list
included all systems for which experimental evidence could be
found in the literature for the pathotypes of interest, which was the
case (see Supplementary Material).
Phylogenetic analyses
We extracted one 16S sequence from one representative
genome of each pathotype. The sequences were aligned with
MUSCLE [81] and the alignment manually corrected. We built a
phylogenetic tree using PhyML with the GTR+C(4) model [84].
We then applied two methods to evaluate the phylogenetic signal
in the ID50 data: Blomberg’s K statistic [41] and Pagel’s Lambda
[42]. K, Lambda and the respective p-values were computed
in R using the ape package [85] and the phylosig function
(http://anolis.oeb.harvard.edu/,liam/R-phylogenetics/phylosig/
v0.2/phylosig.R).
Collection of data from literature
Data on infectious dose, motility, quorum sensing and bacterial
interactions with the immune system were retrieved from the
literature. For motility and most traits we first followed Bergey’s
Manual of Systematic Bacteriology [48]. For infectious dose we
started by using a few reference works [32,34,86–88] as well as the
reference websites of the FDA (http://www.fda.gov/Food/
FoodSafety/FoodborneIllness/FoodborneIllnessFoodbornePatho-
gensNaturalToxins/BadBugBook/), the CDC (http://www.wads-
worth.org/testing/biodefense/) and the Public Health Agency
of Canada (http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/).
These were then complemented with direct searches of primary
literature (see Table S1 in Text S1). All these searches were done
using PubMed, the Web of Science and Google Scholar with
appropriate keywords. Minimal generation time data was retrieved
from the supplementary material of [51], with some new data
retrieved from the primary literature. All data tables and
bibliographic references are published in Supplementary Material
(see Tables S1 to S6 in Text S1).
Supporting Information
Text S1 Contains Table S1 (Infectious dose data), Table S2
(Data on capacity to kill professional phagocytes or survive/
replicate inside them), Table S3 (Reference genomes in GenBank),
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minimum generation times, and genome size data), Table S6
(Data on quorum-sensing). The Text S1 also contains explanatory
notes for all tables and references.
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